3. Conclusion
The central role played by polysaccharides in various biological systems, and the rapid expansion of glycoscience, make this family of molecules essential for the development of new therapeutic solutions. What's more, the diversity of marine polysaccharides' origins (ecosystems and organisms) opens up an immense field of exploration for the discovery of new structures, often impossible to synthesize, and opens up new prospects in the fields of biotechnology and human health. An abundance of literature clearly demonstrates the potential of algal polysaccharides for therapeutic responses in major pathologies: cardiovascular, inflammatory, infectious and cancerous. However, with the recent development of bacterial genetic engineering and glycoscience, bacterial polysaccharides should be able to dethrone polysaccharides of plant and animal origin for healthcare applications. Indeed, bacterial...
Exclusive to subscribers. 97% yet to be discovered!
You do not have access to this resource.
Click here to request your free trial access!
Already subscribed? Log in!
The Ultimate Scientific and Technical Reference
This article is included in
Healthcare technologies
This offer includes:
Knowledge Base
Updated and enriched with articles validated by our scientific committees
Services
A set of exclusive tools to complement the resources
Practical Path
Operational and didactic, to guarantee the acquisition of transversal skills
Doc & Quiz
Interactive articles with quizzes, for constructive reading
Conclusion
Bibliography
Directory
Manufacturers – Suppliers – Distributors (non-exhaustive list)
The main industrial producers of phycocolloids are :
Cargill http://www.cargillfoods.com/emea/en/products/hydrocolloids/index.jsp
Exclusive to subscribers. 97% yet to be discovered!
You do not have access to this resource.
Click here to request your free trial access!
Already subscribed? Log in!
The Ultimate Scientific and Technical Reference